Deprecated: preg_match_all(): Passing null to parameter #2 ($subject) of type string is deprecated in /home/naija/public_html/wp-includes/media.php on line 1839

Deprecated: preg_split(): Passing null to parameter #2 ($subject) of type string is deprecated in /home/naija/public_html/wp-includes/formatting.php on line 3506

Deprecated: preg_split(): Passing null to parameter #2 ($subject) of type string is deprecated in /home/naija/public_html/wp-includes/formatting.php on line 3506

Deprecated: preg_match_all(): Passing null to parameter #2 ($subject) of type string is deprecated in /home/naija/public_html/wp-includes/media.php on line 1839

Deprecated: preg_split(): Passing null to parameter #2 ($subject) of type string is deprecated in /home/naija/public_html/wp-includes/formatting.php on line 3506

Deprecated: preg_split(): Passing null to parameter #2 ($subject) of type string is deprecated in /home/naija/public_html/wp-includes/formatting.php on line 3506
Covid-19

World’s First COVID 19 Pill Launched in Britain

World’s First COVID 19 Pill Launched in Britain

  • Britain has become the first country in the world to approve a COVID 19 pill in the fight against the pandemic
  • The antiviral pill was developed in joint efforts by U.S.-based Merck & Co Inc (MRK.N) and Ridgeback Biotherapeutics
  • Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) have recommended use in people with mild to moderate COVID 19

The United Kingdom has become the first country in the world to approve a COVID 19 pill that was developed by Merck and Ridgeback Biotherapeutics.

The Medicines and Healthcare products Regulatory Agency (MHRA) has recommended that the drugs be given to people who test positive for the deadly virus within five days of symptom onset.

The molnupiravir is the first oral antiviral medicine for COVID 19 to be approved, marking progress in the fight against the pandemic.

Treatments to tackle the deadly virus have mostly come in the form of vaccines, aimed at reducing its occurrence.

The green light for the use of the vaccine comes just before the vaccine may be approved in the United States.

US advisers will meet later this month to vote on the use of the COVID 19 antiviral pill in the country.

Data from the study of Merck’s molnupiravir shows that it could reduce the chance of death or hospitalization by 50% in people at risk of developing severe COVID-19 when it is used early.

The drug has been mechanized to cause errors in the genetic code of the virus. It is administered in pills taken twice daily for 5 days.

Read also: Pfizer Vaccine Effect Drops After 6 Months

The UK’s speedy approval of the COVID 19 pill comes as a result of the country struggling to tame the spread of the virus.

COVID 19 pill

The country averages new daily infections of 40,000, second only to the US worldwide.

Follow Naija.fm on our social media handles FacebookInstagram, and Twitter to keep up with trending news, breaking news, entertainment news, and hot gist.

Show More

Related Articles

Back to top button